Literature DB >> 9568177

Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.

T Naka1, N Toyota, T Kaneko, N Kaibara.   

Abstract

Many genes participate in the regulation of cell cycle progression from G1 to S phase. Functional loss of one or more of these genes has been reported to be associated with carcinogenesis and/or tumor progression and poor prognosis in many cancers. In a series of 126 patients with hepatocellular carcinoma (HCC), we immunohistochemically evaluated tumor expression of the cell cycle-related gene protein products of Rb, p21 (WAF1), and p53. Positive immunostaining for Rb, p21, and mutant p53 protein was detected in 58%, 33%, and 37% of the tumors, respectively. The proportion of HCCs exhibiting aberrant p53 protein expression increased significantly with advancing stage of disease (p < 0.001), poorer histological classification of differentiation (p < 0.01), and increasing tumor size (p < 0.01). A decrease in the proportion of HCCs expressing p21 protein was also associated with advancing clinical stage of disease (p < 0.01), and larger tumor size (p < 0.05). The only clinicopathological feature found to be associated with Rb status, was intrahepatic metastasis, which occurred with a higher frequency in HCCs exhibiting positive immunoreactivity for Rb protein expression (p < 0.05). Multivariate survival analysis revealed that, amongst the protein products of the different genes evaluated, only positive immunostaining for aberrant p53 protein expression served as an independent prognostic indicator, being significantly associated with worse survival in patients with HCC (p = 0.023). Analysis for relationships between gene products showed an inverse correlation between expression of aberrant p53 protein and p21 protein (p < 0.01), and also an inverse correlation between p21 protein and Rb protein expression (p < 0.05) in these cases of HCC. These findings demonstrate that positive immunostaining for mutant p53 protein expression is a significant indicator of tumor progression and poor prognosis, confirm that p21 protein expression is induced in a p53-dependent manner, and suggest that Rb protein expression may be regulated to some extent by p21 in HCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568177

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

Authors:  C Wan; S Hou; R Ni; L Lv; Z Ding; X Huang; Q Hang; S He; Y Wang; C Cheng; X X Gu; G Xu; A Shen
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

3.  Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.

Authors:  H Iida; M Honda; H F Kawai; T Yamashita; Y Shirota; B-C Wang; H Miao; S Kaneko
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.

Authors:  You Wang; Ya-Nan Yu; Shu Song; Tie-Jun Li; Jing-Ying Xiang; Hong Zhang; Mu-Dan Lu; Fang Ji; Ling-Qing Hu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

5.  TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Ya-nan Ji; Qin Wang; Jun Xue
Journal:  Tumour Biol       Date:  2014-02

Review 6.  Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

Authors:  Jiangbo Liu; Qingyong Ma; Min Zhang; Xinshuai Wang; Dong Zhang; Wei Li; Fengfei Wang; Erxi Wu
Journal:  Eur J Cancer       Date:  2012-03-27       Impact factor: 9.162

7.  Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.

Authors:  Mei-Fang Zhang; Zhi-Yi Zhang; Jia Fu; Yu-Feng Yang; Jing-Ping Yun
Journal:  J Transl Med       Date:  2009-12-22       Impact factor: 5.531

8.  Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma.

Authors:  Hai Song; Shuang-Luo Xia; Cheng Liao; Yi-Liang Li; Yi-Fei Wang; Tsai-Ping Li; Mu-Jun Zhao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Ping Zhan; Ya-Nan Ji
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

10.  Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.

Authors:  P Pontisso; F Calabrese; L Benvegnù; M Lise; C Belluco; M G Ruvoletto; M Marino; M Valente; D Nitti; A Gatta; G Fassina
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.